PCI Biotech Holding ASA (OSL:PCIB)
1.410
0.00 (0.00%)
Aug 1, 2025, 4:13 PM CET
PCI Biotech Holding ASA Market Cap
PCI Biotech Holding ASA has a market cap or net worth of 52.63 million as of August 1, 2025. Its market cap has decreased by -20.34% in one year.
Market Cap
52.63M
Enterprise Value
26.27M
Revenue
6.74M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.41
Market Cap Chart
Since June 23, 2008, PCI Biotech Holding ASA's market cap has decreased from 97.50M to 52.63M, a decrease of -46.02%. That is a compound annual growth rate of -3.54%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 1, 2025 | 52.63M | 18.69% |
Dec 30, 2024 | 44.34M | -43.29% |
Dec 29, 2023 | 78.20M | 2.20% |
Dec 30, 2022 | 76.52M | -85.26% |
Dec 30, 2021 | 519.21M | -50.14% |
Dec 30, 2020 | 1.04B | -63.57% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Medistim ASA | 3.98B |
Nordhealth AS | 3.04B |
Photocure ASA | 1.68B |
Vistin Pharma ASA | 1.08B |
Omda AS | 1.05B |
ArcticZymes Technologies ASA | 978.02M |
Gentian Diagnostics ASA | 913.00M |
Thor Medical ASA | 860.25M |